A constitutively active ERBB4/HER4 allele with enhanced transcriptional coactivation and cell-killing activities

Oncogene

Volumn 26, Issue 3, 2007, Pages 462-466

  Vidal, G A ^a   Clark, D E ^a   Marrero, L ^b   Jones, F E ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; EGFR family; Nuclear translocation; STAT5A; Transactivation

Indexed keywords

BETA CASEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 4; GLUTAMIC ACID; VALINE;

ALLELE; AMINO ACID SUBSTITUTION; ANIMAL CELL; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL KILLING; CELL STRAIN HEK293; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; EPIDERMAL GROWTH FACTOR RECEPTOR 4 GENE; GENE ACTIVITY; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; ONCOGENE; ONCOGENE NEU; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; STATISTICAL SIGNIFICANCE; TRANSCRIPTION INITIATION; WILD TYPE;

ALLELES; APOPTOSIS; BREAST NEOPLASMS; CASEINS; CELL NUCLEUS; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY; MALE; OVARIAN NEOPLASMS; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); PROSTATIC NEOPLASMS; PROTEIN TRANSPORT; RECEPTOR, EPIDERMAL GROWTH FACTOR; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; TYROSINE;

EID: 33846296953     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209794     Document Type: Article

References (21)

1. Bargmann CI, Hung MC, Weinberg RA.(1986). Nature 310: 226-230.
2. Bargmann CI, Weinberg RA.(1988). Proc Natl Acad Sci USA 85: 5394-5398.
3. Barnes NL, Khavari S, Boland GP, Cramer A, Knox WF, Bundred NJ.(2005). Clin Cancer Res 11: 2163-2168.
4. Burke CL, Lemmon MA, Coren BA, Engelman DM, Stern DF.(1997). Oncogene 14: 687-696.
5. Clark DE, Williams CC, Duplessis TT, Moring KL, Notwick AR, Lane WS et al.(2005). J Biol Chem 280: 24175-24180.
6. Jones FE, Golding JP, Gassmann M.(2003). Cell Cycle 2: 555-559.
7. Jones FE, Welte T, Fu X-Y, Stern DF.(1999). J Cell Biol 147: 77-87.
8. Kew TY, Bell JA, Pinder SE, Denley H, Srinivasan R, Gullick WJ et al.(2000). Br J Cancer 82: 1163-1170.
9. Long W, Wagner K-U, Lloyd KCK, Binart N, Shillingford JM, Hennighausen L et al.(2003). Development 130: 5257-5268.
10. Miloso M, Mazzotti M, Vass WC, Beguinot L.(1995). J Biol Chem 270: 19557-19562.
11. Naresh A, Long W, Vidal GA, Wimley WC, Marrero L, Sartor CI et al.(2006). Cancer Res 66: 6412-6420.
12. Ni C-Y, Murphy MP, Golde TE, Carpenter G.(2001). Science 294: 2179-2181.
13. Segatto O, King CR, Pierce JH, Di Fiore PP, Aaronson SA. (1988). Mol Cell Biol 8: 5570-5574.
14. Srinivasan R, Poulsom R, Hurst HC, Gullick WJ.(1998). J Pathol 185: 236-245.
15. Stern DF, Kamps MP, Cao H.(1988). Mol Cell Biol 8: 3969-3973.
16. Tidcombe H, Jackson-Fisher A, Mathers K, Stern DF, Gassmann M, Golding JP.(2003). Proc Natl Acad Sci USA 100: 8281-8286.
17. Vidal GA, Naresh A, Marrero L, Jones FE.(2005). J Biol Chem 280: 19777-19783.
18. Weiner DB, Liu J, Cohen JA, Williams WV, Greene MI. (1989). Nature 339: 230-231.
19. Williams CC, Allison JG, Vidal GA, Burow ME, Beckman BS, Marrero L et al.(2004). J Cell Biol 167: 469-478.
20. Witton CJ, Reeves JR, Going JJ, Cooke TG, Bartlett JM. (2003). J Pathol 200: 290-297.
21. Yarden Y, Sliwkowski MX.(2001). Nat Rev Mol Cell Biol 2: 127-137.